Surprisingly Useful AI Article Enhancements
Wearable health company Whoop has closed a $575 million Series G funding round at a $10.1 billion valuation, with backing from a mix of institutional investors, healthcare organisations and high-profile athletes.
The round was led by Collaborative Fund and includes participation from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital, Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures and Bullhound Capital.
Individual investors include footballers Cristiano Ronaldo and Virgil van Dijk, basketball players LeBron James and Reggie Miller, golfers Rory McIlroy and Shane Lowry, cyclist Mathieu van der Poel, musician Niall Horan and influencer Karen Wazen.
The Boston-headquartered company has now raised more than $900 million in venture capital since its founding in 2012.
Growth figures underpin the raise
Whoop reported that bookings grew 103 per cent year-over-year in 2025, exiting the year at a $1.1 billion run rate. The company now counts more than 2.5 million members globally, ships to 56 countries and operates in six languages.
The company also operated cash flow positive in 2025.
Whoop is hiring for more than 600 new roles this year to support research and development and international expansion.
Where the money will go
Proceeds from the Series G will fund further growth in the United States and international expansion across Europe, the GCC, Latin America and Asia.
The company’s stated ambition is to build a personal health platform focused on extending healthspan, optimising performance and preventing disease.
“Our raise brings together sophisticated investors, leading health institutions and iconic global athletes behind the mission to unlock human performance and healthspan,” Whoop Founder and Chief Executive Officer Will Ahmed explained.
“We are building the personal health platform that people use to improve their health and livelihood.”
Abbott joins as strategic investor
Healthcare company Abbott has come on board as a strategic investor. Abbott’s portfolio spans diagnostics, medical devices, nutrition and generic medicines.
The two companies share a focus on empowering individuals to manage their own health, and the partnership signals Whoop’s intent to move deeper into the healthcare space beyond its roots in fitness and athletic performance tracking.
The platform in detail
Whoop’s platform is built on more than 24 billion hours of physiological data and purpose-built AI models. It delivers health insights across sleep, recovery, strain, fitness and longevity through a 24/7 wearable device with a 14-day battery life.
The platform includes an FDA-cleared ECG, a healthspan longevity feature, blood pressure insights and blood biomarker analysis through its Advanced Labs offering.
Related: Best Business Laptops for work & school
Related: Best Gaming Laptops
Related: Best Portable Laptop
The company reports that members open the app an average of more than eight times per day, using it to track sleep quality, recovery status, training intensity, nutrition and stress.
Research cited by the company indicates that daily Whoop users log more than 90 additional minutes of exercise per week, get over two extra hours of sleep and have 10 per cent higher heart rate variability.
Athletes back the platform
Cristiano Ronaldo, who is both an investor and global ambassador for the brand, spoke to the role Whoop plays in his routine.
“Whoop has become one of the most important tools I use to support my long-term health,” Ronaldo noted. “I am proud to participate in this round because I believe in the future we are building together. No other company has created a health platform this powerful that people are proud to wear.”
Preventive health as the pitch
The funding comes as Whoop positions itself at the intersection of wearable technology and preventive healthcare. The company argues that chronic disease is rising globally while many healthcare systems remain oriented toward reactive care.
Advances in AI and continuous biometric data are enabling a different approach, one that predicts risk, guides behaviour and aims to improve health outcomes in real time, according to the company.
Whoop’s member base spans athletes, military operators, executives and artists. The company frames the platform as a tool not just for performance optimisation but for identifying early warning signs and reducing the risk of serious health events.
To learn more, visit whoop.com.
Last Updated on April 4, 2026 by Nick Ross
